Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal epithelial cell adhesion sites are specialized intercellular junctions that maintain the integrity, barrier function, and homeostasis of the intestinal epithelium. These adhesion sites are composed of several distinct molecular complexes located along the lateral membrane between adjacent epithelial cells. The primary types include tight junctions (TJs), adherens junctions (AJs), and desmosomes (DMs). These junctions are crucial for maintaining the epithelial barrier against pathogens and toxins, while also allowing for selective nutrient absorption. Disruption or mutation in these molecules can lead to increased permeability ('leaky gut'), inflammation, autoimmune diseases, cancer progression, or developmental defects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal Epithelial Cell Adhesion Sites.